OTULFI
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for OTULFI, covering 2024-09-27 to 2026-03-25. Get the full timeline:
Most recent: EMA Authorised: Otulfi (ustekinumab) — Fresenius Kabi Deutschland GmbH
9 regulatory and trial events tracked for OTULFI, covering 2024-09-27 to 2026-03-25. Get the full timeline:
Most recent: EMA Authorised: Otulfi (ustekinumab) — Fresenius Kabi Deutschland GmbH